Opinion

Video

Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

Video content above is prompted by the following question(s):

  • Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?
Related Videos
5 experts are featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo